ARCHIVES

AACR Journal Publishes a Henschke Letter Without Disclosure of Conflicts.

This article is from The Cancer Letter archive.

Vol. 34 No. 16 | April 25, 2008

Download PDF Visit The Full Archive

Related Articles

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

June 7, 2002